Stock futures are little changed after the S&P 500 closes at another record: Live updates

U.S. futures were little changed after the S&P 500 and Nasdaq hit fresh records, with S&P 500 futures and Nasdaq 100 futures both about 0.1% lower and Dow futures down 41 points. Micron Technology surged 19% to briefly lift its market cap above $1 trillion, while after-hours losses hit Zscaler (-19%) on weak guidance and Insulet (-8%) on a device correction. The rally was supported by easing Iran tensions, but Citi's Drew Pettit warned higher 10-year yields near 4.50% and firmer inflation expectations limit further upside in equities.

Analysis

The market is increasingly rewarding duration-on-duration exposure: AI semis and the few adjacent infrastructure names with visible pricing power are absorbing index-level inflows while everything else is being forced into the role of funding source. That creates a fragile tape: breadth deterioration can persist for weeks even as the headline index grinds higher, but it also raises the odds of sharp factor mean reversion if rates back up another 20-30 bps or if one of the megacap earnings prints disappoints. The key second-order effect is that leadership concentration makes the market more sensitive to any change in funding conditions than the calm surface suggests.

The post-close reactions in software and medtech signal a bifurcation between “secular growth” and “execution trust.” A guide-down in enterprise security is more damaging than a one-night gap lower because it can force portfolio de-grossing across the profitable SaaS complex, especially names with similar valuation/Rule-of-40 optics. In medtech, a product correction is usually less about direct revenue loss and more about channel behavior: hospitals and durable medical equipment distributors tend to slow reorders immediately, which can create a multi-quarter demand air pocket even after the headline issue is contained.

Semis remain the cleanest relative winner, but the move is increasingly crowded. The market is now pricing not just AI capex persistence, but also the assumption that margin expansion can coexist with a stable rate backdrop; that is a high bar if inflation expectations keep edging up. If geopolitics continues to de-risk, it helps cyclicals at the margin, but the bigger macro variable is still rates: higher real yields compress the multiple of every long-duration asset, including the very stocks driving the index to records.

Consensus is probably underestimating how quickly leadership can rotate if the next few earnings reports do not broaden out. With several consumer and retail names reporting into this tape, a soft guide from discretionary could confirm that lower-income demand is weakening under the surface even as large-cap tech masks it. That would be the first real challenge to the ‘everything is fine’ narrative and could trigger a fast unwind in the market’s most crowded growth exposures.

Key Decisions for Investors

• Reduce gross in high-multiple SaaS into strength; use any 1-2 day bounce in ZS-like names to trim longs, with a 1-3 week horizon. Risk/reward favors de-risking because one more guide-down can force systematic factor selling across the cohort.
• Buy MU pullbacks on a 2-4 week horizon versus short a basket of slower-growing hardware/semis with less pricing power. The setup is favorable as AI memory demand remains the clearest earnings revision driver, but trail tightly if the 10-year moves materially above recent ranges.
• Initiate a short-term pair: long semis/infrastructure beneficiaries, short broad software ETF exposure for 2-6 weeks. This captures continued capex leadership while hedging against valuation compression if rates stay sticky.
• Avoid chasing medtech weakness until the scope of the product correction is clearer; if PODD stabilizes after the first flush, consider a tactical long only after management quantifies recall containment and reorder timing. Best risk/reward is after panic, not immediately.
• Set a macro hedge with put spreads on the Nasdaq 100 into the next CPI/rates scare over the next 30-60 days. The market is vulnerable to multiple compression because leadership concentration has made index returns unusually sensitive to higher yields.